Daniel J Smith1, Gregory J Anderson2, Scott C Bell3, David W Reid4. 1. Department of Thoracic Medicine, The Prince Charles Hospital, Rode Road, Chermside, Brisbane, Queensland 4032, Australia; School of Medicine, University of Queensland, 288 Herston Road, Herston, Brisbane, Queensland 4029, Australia; The Iron Metabolism Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Herston, Queensland 4029, Australia. Electronic address: Daniel_j_smith@health.qld.gov.au. 2. School of Medicine, University of Queensland, 288 Herston Road, Herston, Brisbane, Queensland 4029, Australia; The Iron Metabolism Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Herston, Queensland 4029, Australia. 3. Department of Thoracic Medicine, The Prince Charles Hospital, Rode Road, Chermside, Brisbane, Queensland 4032, Australia; School of Medicine, University of Queensland, 288 Herston Road, Herston, Brisbane, Queensland 4029, Australia; Queensland Children's Medical Research Institute, Royal Children's Hospital, Herston Road, Herston, Queensland 4029, Australia. 4. Department of Thoracic Medicine, The Prince Charles Hospital, Rode Road, Chermside, Brisbane, Queensland 4032, Australia; School of Medicine, University of Queensland, 288 Herston Road, Herston, Brisbane, Queensland 4029, Australia; The Iron Metabolism Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Herston, Queensland 4029, Australia.
Abstract
BACKGROUND: Bio-active trace metals have been identified in respiratory tract secretions of subjects with lung disease and may potentially influence bacterial virulence, inflammation and disease severity. We measured a diverse range of metal ions in sputum samples from subjects with CF and non-CF bronchiectasis (NCFB) compared to healthy controls and examined their relationship to airway inflammation, disease severity and the presence of bacterial pathogens. METHODS: We studied 45 subjects with CF, 8 with NCFB and 8 healthy controls. Metal concentrations were measured in sputum supernatant by inductively-coupled plasma mass spectrometry and correlated with sputum inflammatory cell counts, lactate dehydrogenase (LDH) and interleukin (IL)-8 concentrations, atmospheric particulate matter, lung function, clinical status and participant demographics. RESULTS: Sputum from subjects with CF and NCFB contained increased concentrations of magnesium, calcium, iron and zinc. Metal ion concentrations correlated positively with LDH levels. The concentrations of magnesium, iron and zinc positively correlated with IL-8. A sub-group of CF subjects with severe lung disease demonstrated increased sputum molybdenum concentrations. CONCLUSION: Elevated concentrations of sputum metal ions appear to be associated with cell/tissue necrosis and inflammation in subjects with CF and NCFB. Sputum molybdenum concentrations may be a biomarker of severe CF airway disease.
BACKGROUND: Bio-active trace metals have been identified in respiratory tract secretions of subjects with lung disease and may potentially influence bacterial virulence, inflammation and disease severity. We measured a diverse range of metal ions in sputum samples from subjects with CF and non-CF bronchiectasis (NCFB) compared to healthy controls and examined their relationship to airway inflammation, disease severity and the presence of bacterial pathogens. METHODS: We studied 45 subjects with CF, 8 with NCFB and 8 healthy controls. Metal concentrations were measured in sputum supernatant by inductively-coupled plasma mass spectrometry and correlated with sputum inflammatory cell counts, lactate dehydrogenase (LDH) and interleukin (IL)-8 concentrations, atmospheric particulate matter, lung function, clinical status and participant demographics. RESULTS: Sputum from subjects with CF and NCFB contained increased concentrations of magnesium, calcium, iron and zinc. Metal ion concentrations correlated positively with LDH levels. The concentrations of magnesium, iron and zinc positively correlated with IL-8. A sub-group of CF subjects with severe lung disease demonstrated increased sputum molybdenum concentrations. CONCLUSION: Elevated concentrations of sputum metal ions appear to be associated with cell/tissue necrosis and inflammation in subjects with CF and NCFB. Sputum molybdenum concentrations may be a biomarker of severe CF airway disease.
Authors: Manita Guragain; Michelle M King; Kerry S Williamson; Ailyn C Pérez-Osorio; Tatsuya Akiyama; Sharmily Khanam; Marianna A Patrauchan; Michael J Franklin Journal: J Bacteriol Date: 2016-01-11 Impact factor: 3.490
Authors: Alex H Gifford; Sven D Willger; Emily L Dolben; Lisa A Moulton; Dana B Dorman; Heather Bean; Jane E Hill; Thomas H Hampton; Alix Ashare; Deborah A Hogan Journal: Infect Immun Date: 2016-09-19 Impact factor: 3.441
Authors: Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan Journal: Respir Res Date: 2021-04-29
Authors: Akanksha Rajput; Hannah Tsunemoto; Anand V Sastry; Richard Szubin; Kevin Rychel; Siddharth M Chauhan; Joe Pogliano; Bernhard O Palsson Journal: Nucleic Acids Res Date: 2022-09-23 Impact factor: 19.160
Authors: Akanksha Rajput; Hannah Tsunemoto; Anand V Sastry; Richard Szubin; Kevin Rychel; Joseph Sugie; Joe Pogliano; Bernhard O Palsson Journal: Nucleic Acids Res Date: 2022-04-22 Impact factor: 19.160
Authors: Yuliang Xie; Lin Lu; Xiao Xiao Tang; Thomas O Moninger; Tony Jun Huang; David A Stoltz; Michael J Welsh Journal: Dev Cell Date: 2020-07-29 Impact factor: 12.270
Authors: Alesha C Stewart; Christopher R Bethel; Jamie VanPelt; Alex Bergstrom; Zishuo Cheng; Callie G Miller; Cameron Williams; Robert Poth; Matthew Morris; Olivia Lahey; Jay C Nix; David L Tierney; Richard C Page; Michael W Crowder; Robert A Bonomo; Walter Fast Journal: ACS Infect Dis Date: 2017-10-11 Impact factor: 5.084
Authors: Holly M Jacobs; Lindsey O'Neal; Edward Lopatto; Daniel J Wozniak; Thomas Bjarnsholt; Matthew R Parsek Journal: J Bacteriol Date: 2022-04-13 Impact factor: 3.476